Abstract
Free full text
Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies.
Abstract
We have attempted to express the Helicobacter pylori vacuolating cytotoxin in Escherichia coli. Although the 95-kDa VacA polypeptide was expressed abundantly, it completely lacked any biological activity. In addition, this material failed to induce neutralizing antibodies after immunization of rabbits. In contrast, highly purified high-molecular-mass cytotoxin from the supernatant of H. pylori cultures was active in a HeLa cell assay and effectively induced a neutralizing response in rabbits. Neutralizing sera were shown to contain a high proportion of antibodies which recognized conformational epitopes found only on the native toxin. The data indicate that toxin-neutralizing epitopes are conformational and that potential vaccines based on the cytotoxin may benefit from the use of the intact molecule.
Full Text
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blaser MJ. Helicobacter pylori: microbiology of a 'slow' bacterial infection. Trends Microbiol. 1993 Oct;1(7):255–260. [Abstract] [Google Scholar]
- Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5791–5795. [Europe PMC free article] [Abstract] [Google Scholar]
- Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem. 1992 May 25;267(15):10570–10575. [Abstract] [Google Scholar]
- Cover TL, Tummuru MK, Cao P, Thompson SA, Blaser MJ. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem. 1994 Apr 8;269(14):10566–10573. [Abstract] [Google Scholar]
- Leunk RD. Production of a cytotoxin by Helicobacter pylori. Rev Infect Dis. 1991 Jul-Aug;13 (Suppl 8):S686–S689. [Abstract] [Google Scholar]
- Marchetti M, Aricò B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science. 1995 Mar 17;267(5204):1655–1658. [Abstract] [Google Scholar]
- Marchini A, Massari P, Manetti R, Olivieri R. Optimized conditions for the fermentation of Helicobacter pylori and production of vacuolating cytotoxin. FEMS Microbiol Lett. 1994 Nov 15;124(1):55–59. [Abstract] [Google Scholar]
- Papini E, Bugnoli M, De Bernard M, Figura N, Rappuoli R, Montecucco C. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells. Mol Microbiol. 1993 Jan;7(2):323–327. [Abstract] [Google Scholar]
- Pizza M, Covacci A, Bartoloni A, Perugini M, Nencioni L, De Magistris MT, Villa L, Nucci D, Manetti R, Bugnoli M, et al. Mutants of pertussis toxin suitable for vaccine development. Science. 1989 Oct 27;246(4929):497–500. [Abstract] [Google Scholar]
- Rappuoli R, Podda A, Pizza M, Covacci A, Bartoloni A, de Magistris MT, Nencioni L. Progress towards the development of new vaccines against whooping cough. Vaccine. 1992;10(14):1027–1032. [Abstract] [Google Scholar]
- Schmitt W, Haas R. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol Microbiol. 1994 Apr;12(2):307–319. [Abstract] [Google Scholar]
- Stein PE, Boodhoo A, Armstrong GD, Cockle SA, Klein MH, Read RJ. The crystal structure of pertussis toxin. Structure. 1994 Jan 15;2(1):45–57. [Abstract] [Google Scholar]
- Telford JL, Covacci A, Ghiara P, Montecucco C, Rappuoli R. Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential new therapies and vaccines. Trends Biotechnol. 1994 Oct;12(10):420–426. [Abstract] [Google Scholar]
- Telford JL, Ghiara P, Dell'Orco M, Comanducci M, Burroni D, Bugnoli M, Tecce MF, Censini S, Covacci A, Xiang Z, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med. 1994 May 1;179(5):1653–1658. [Europe PMC free article] [Abstract] [Google Scholar]
- Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, Covacci A. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun. 1995 Jan;63(1):94–98. [Europe PMC free article] [Abstract] [Google Scholar]
Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)
Full text links
Read article at publisher's site: https://doi.org/10.1128/iai.63.11.4476-4480.1995
Read article for free, from open access legal sources, via Unpaywall: https://iai.asm.org/content/iai/63/11/4476.full.pdf
Free after 4 months at iai.asm.org
http://iai.asm.org/cgi/reprint/63/11/4476
Free to read at iai.asm.org
http://iai.asm.org/cgi/content/abstract/63/11/4476
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1128/iai.63.11.4476-4480.1995
Article citations
Construction and preservation of a stable and highly expressed recombinant Helicobacter pylori vacuolating cytotoxin A with apoptotic activity.
BMC Microbiol, 21(1):229, 18 Aug 2021
Cited by: 2 articles | PMID: 34407768 | PMCID: PMC8371779
A Helicobacter pylori Vacuolating Cytotoxin A: Mouse DHFR Fusion Protein Triggers Dye Release from Liposomes.
Curr Microbiol, 75(2):223-230, 14 Oct 2017
Cited by: 0 articles | PMID: 29032467
Use of VacA as a Vaccine Antigen.
Toxins (Basel), 8(6):E181, 08 Jun 2016
Cited by: 7 articles | PMID: 27338474 | PMCID: PMC4926147
Review Free full text in Europe PMC
VacA, the vacuolating cytotoxin of Helicobacter pylori, binds to multimerin 1 on human platelets.
Thromb J, 11(1):23, 12 Nov 2013
Cited by: 17 articles | PMID: 24219705 | PMCID: PMC3842841
Type V Secretion: the Autotransporter and Two-Partner Secretion Pathways.
EcoSal Plus, 4(1), 01 Sep 2010
Cited by: 3 articles | PMID: 26443787 | PMCID: PMC4229083
Go to all (63) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Production of monoclonal antibodies neutralizing vacuolation of cultured cells by Helicobacter pylori cytotoxin.
FEMS Microbiol Lett, 168(2):277-282, 01 Nov 1998
Cited by: 2 articles | PMID: 9835039
High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients.
Int J Cancer, 56(1):56-60, 01 Jan 1994
Cited by: 29 articles | PMID: 8262677
Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori.
J Clin Invest, 90(3):913-918, 01 Sep 1992
Cited by: 45 articles | PMID: 1522241 | PMCID: PMC329946
Vacuolating cytotoxin A (VacA) - A multi-talented pore-forming toxin from Helicobacter pylori.
Toxicon, 118:27-35, 20 Apr 2016
Cited by: 17 articles | PMID: 27105670
Review